The pharma major beat analysts' expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto. The lender is planning a new EUR400 million share buyback and ...
The pharma major beat analysts' expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto. The lender is planning a new EUR400 million share buyback and ...
Want to share your experience with this dealership? Service department is responsive, friendly, and professional. I had a tire with a slow leak, and they found a nail in the sidewall. Service ...